Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Treatment for women news

Show

From To
UK guidelines on treatment of HIV in pregnancy give green light to efavirenz

New UK draft guidelines on the management of HIV infection in pregnant women recommend that efavirenz-based treatment should no longer be avoided in pregnant women or women who

Published
17 February 2012
By
Keith Alcorn
HIV Worsens Bone Loss After Menopause

Compared to a control group, postmenopausal women with HIV infection had higher rates of bone loss and could well have a higher risk for fracture as they age, according to the researchers who conducted the study.

Published
03 January 2012
From
Medscape (requires free registration)
Tenofovir PrEP arm dropped in women's HIV prevention trial

A major HIV prevention trial comparing a tenofovir microbicide with two forms of oral pre-exposure prophylaxis as HIV prevention methods for women is to halt investigation of

Published
29 September 2011
By
Keith Alcorn
Over half of pregnant UK women with HIV present late for antenatal care

Women in the UK who have HIV (previously diagnosed or not) are more than twice as likely to present late for antenatal care than HIV-negative women, a survey

Published
15 September 2011
By
Gus Cairns
Pre-term delivery in mothers receiving HIV treatment: more research needed before changing guidelines

HIV-infected pregnant women on a protease-inhibitor (PI) triple antiretroviral regimen were twice as likely to have a preterm delivery compared to those on a triple nucleoside reverse transcriptase

Published
16 August 2011
By
Carole Leach-Lemens
Zambian study shows importance of early HIV test and fast ART for pregnant women

Starting ART at least 13 weeks before giving birth provides the greatest benefits in prevention of mother-to-child transmission (PMTCT), Carla J Chibwesha and colleagues reported in a retrospective

Published
15 July 2011
By
Carole Leach-Lemens
Triple ART reduces maternal death, premature and still birth, Mozambique / Malawi study shows

Women in Malawi and Mozambique on triple ART for three months or longer before giving birth were thirteen times less likely to die than women with no

Published
12 July 2011
By
Carole Leach-Lemens
Once-daily nevirapine approved in United States

The US Food and Drug Administration has approved a new once-daily extended release formulation of nevirapine, known as Viramune XR. The new 400mg tablet will provide an

Published
29 March 2011
By
Keith Alcorn
Adverse effects of ART use in pregnancy: prematurity continues to raise concerns

Premature births in HIV-positive women continue to be a concern, and need to anticipated and managed actively in developing countries, researchers said last week at the 18th Conference

Published
10 March 2011
By
Carole Leach-Lemens
Studies in Post-Menopausal Women Reveal Potentially Higher Biological HIV Risk, as Well as Possible Tenofovir Concerns

A little light from CROI 2011 has shone into the dark corners of research into aging women with HIV/AIDS. Two oral presentations compared HIV risk in pre-menopausal versus post-menopausal women.

Published
01 March 2011
From
The BodyPro

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.